OSE Immunotherapeutics
8 clinical trials · Sponsor
◉ Watch OSE Immunotherapeutics
| Record | Firm | Date |
|---|---|---|
| Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor (NCT06472245) | OSE Immunotherapeutics | 2024-12-03 |
| Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas (NCT05751798) | OSE Immunotherapeutics | 2022-12-20 |
| To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults (NCT04885361) | OSE Immunotherapeutics | 2021-05-26 |
| Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis (NCT04882007) | OSE Immunotherapeutics | 2020-10-02 |
| A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours (NCT03990233) | OSE Immunotherapeutics | 2019-04-16 |
| Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects (NCT03980080) | OSE Immunotherapeutics | 2018-12-19 |
Track OSE Immunotherapeutics automatically
Every clearance here is in the API, with alerts when new ones post.